Bitcoin
63845.53
+298
+0.46%
Crude Oil
84.25
+0.35
+0.42%
Gold
2359.9
+5.7
+0.24%
Copper
4.58
+0.04
+0.85%
Silver
27.65
+0.08
+0.29%
Dow Jones
38085.81
-375.12
-0.98%
SP500
5080.64
+37.77
+0.74%
NASDAQ
15594.61
-118.14
-0.76%

CheckMan Stock Market Overview

Trending Stocks

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
8.14
+98.56%
Top Gainers
1,677,757
Top Gainers
3.935
+61.88%
Top Gainers
137,589
Top Gainers
2.46
+34.96%
Top Gainers
1,016,248
Top Gainers
3965
+31.10%
Top Gainers
205,040
Top Gainers
3.2
+29.06%
Top Gainers
2,003,637
Top Gainers
2850
+22.98%
Top Gainers
5,599,544
Top Gainers
3.69
+20.05%
Top Gainers
2,113,316
Top Gainers
47100
+19.96%
Top Gainers
489,308
Top Gainers
133
+19.55%
Top Gainers
408,905
Top Gainers
14.1301
+19.32%
Top Gainers
30,038,586
Top Gainers

Red List

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
1.725
-128.99%
Top Loosers
113,731
Top Loosers
1.124
-48.34%
Top Loosers
108,648
Top Loosers
9.76
-45.90%
Top Loosers
4,737,957
Top Loosers
25.19
-23.38%
Top Loosers
1,403,647
Top Loosers
449.23
-20.88%
Top Loosers
286,844
Top Loosers
4.48
-19.87%
Top Loosers
231,826
Top Loosers
2.24
-19.46%
Top Loosers
344,311
Top Loosers
15.38
-18.73%
Top Loosers
2,496,721
Top Loosers
3.05
-18.36%
Top Loosers
496,610
Top Loosers
2.4
-18.33%
Top Loosers
223,870
Top Loosers

In Today's Headlines

ResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand
09:41
26 Apr 2024
ResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand

ResMed's (RMD) fiscal 2024 third-quarter performance reflects another strong period of execution across the entire business, resulting in impressive top and bottom-line growth.

HCA Healthcare (HCA) Q1 Earnings and Revenues Beat Estimates
09:41
26 Apr 2024
HCA Healthcare (HCA) Q1 Earnings and Revenues Beat Estimates

HCA Healthcare (HCA) came out with quarterly earnings of $5.36 per share, beating the Zacks Consensus Estimate of $5.01 per share. This compares to earnings of $4.93 per share a year ago.

Alibaba Stock Is Rising Amid Longest Winning Streak in a Year. Don't Get Fooled.
09:38
26 Apr 2024
Alibaba Stock Is Rising Amid Longest Winning Streak in a Year. Don't Get Fooled.

The debate continues to rage over Alibaba stock: screaming value buy or value trap?

5 High-Yielding Oversold Stocks with Bullish Ratings
09:37
26 Apr 2024
5 High-Yielding Oversold Stocks with Bullish Ratings

Amid global tensions and some severe market pullbacks, investors might seek refuge in defensive sectors, particularly oversold stocks offering high dividends. With uncertainties looming over geopolitical conflicts and dwindling prospects of the Federal Reserve's rate cuts, it might be wise to turn attention toward resilient stocks poised for potential upside, especially if you're a conservative, long-term, value-orientated investor.

Arthur J. Gallagher (AJG) Q1 Earnings Beat, Revenues Rise Y/Y
09:36
26 Apr 2024
Arthur J. Gallagher (AJG) Q1 Earnings Beat, Revenues Rise Y/Y

Arthur J. Gallagher's (AJG) Q1 results reflect higher adjusted revenues and adjusted EBITDAC across the Brokerage and Risk Management segments, partially offset by higher expenses.

Texas Instruments (TXN) International Revenue in Focus: Trends and Expectations
09:36
26 Apr 2024
Texas Instruments (TXN) International Revenue in Focus: Trends and Expectations

Explore how Texas Instruments' (TXN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

AIA ETF: Not The Best Product Around, But Offers Some Merit
09:35
26 Apr 2024
AIA ETF: Not The Best Product Around, But Offers Some Merit

AIA compares poorly to other competing products in this space. AIA's lack of exposure towards Indian equities could harm its prospects. AIA offers good earnings potential at cheap valuations, and the risk-reward on the charts looks encouraging.

Pfizer Receives FDA Approval for Bleeding Disorder Treatment
09:35
26 Apr 2024
Pfizer Receives FDA Approval for Bleeding Disorder Treatment

The treatment, Beqvez, will be available by prescription to eligible patients this quarter.

V.F. Corporation Is A Strong Buy: This Bargain Stock Is My Top Turnaround For 2024
09:31
26 Apr 2024
V.F. Corporation Is A Strong Buy: This Bargain Stock Is My Top Turnaround For 2024

V.F. Corporation has experienced significant underperformance, resulting in its removal from the S&P 500 Index and a loss of over $34 billion in shareholder value. The company is undergoing a strategic turnaround under new CEO Bracken Darrell, who has a successful track record of turnarounds in previous roles. Activist investor Engaged Capital is involved in the company and has outlined key strategies for the turnaround, including cost reductions, restoring brand autonomy, addressing the capital structure, and governance/board changes.

Cincinnati Financial (CINF) Q1 Earnings Top, Revenues Up Y/Y
09:31
26 Apr 2024
Cincinnati Financial (CINF) Q1 Earnings Top, Revenues Up Y/Y

Cincinnati Financial's (CINF) Q1 results reflect higher premiums, net investment income, improved combined ratio and lower catastrophe losses.